Literature DB >> 20094044

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.

Brian J Reid1, Xiaohong Li, Patricia C Galipeau, Thomas L Vaughan.   

Abstract

The public health importance of Barrett's oesophagus lies in its association with oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma has risen at an alarming rate over the past four decades in many regions of the Western world, and there are indications that the incidence of this disease is on the rise in Asian populations in which it has been rare. Much has been learned of host and environmental risk factors that affect the incidence of oesophageal adenocarcinoma, and data indicate that patients with Barrett's oesophagus rarely develop oesophageal adenocarcinoma. Given that 95% of oesophageal adenocarcinomas arise in individuals without a prior diagnosis of Barrett's oesophagus, what strategies can be used to reduce late diagnosis of oesophageal adenocarcinoma?

Entities:  

Mesh:

Year:  2010        PMID: 20094044      PMCID: PMC2879265          DOI: 10.1038/nrc2773

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  213 in total

1.  Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: a population-based study of natural history.

Authors:  Piers Gatenby; James Ramus; Christine Caygill; Neil Shepherd; Marc Winslet; Anthony Watson
Journal:  Histopathology       Date:  2009-06       Impact factor: 5.087

2.  Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition.

Authors:  Annika Steffen; Matthias B Schulze; Tobias Pischon; Thomas Dietrich; Esther Molina; Maria-Dolores Chirlaque; Aurelio Barricarte; Pilar Amiano; J Ramón Quirós; Rosario Tumino; Amalia Mattiello; Domenico Palli; Paolo Vineis; Claudia Agnoli; Gesthimani Misirli; Paolo Boffetta; Rudolf Kaaks; Sabine Rohrmann; H Bas Bueno-de-Mesquita; Petra H M Peeters; Anne M May; Elizabeth A Spencer; Naomi E Allen; Sheila Bingham; Anne Tjønneland; Jytte Halkjaer; Kim Overvad; Jakob Stegger; Jonas Manjer; Björn Lindkvist; Göran Hallmanns; Roger Stenling; Eiliv Lund; Elio Riboli; Carlos A Gonzalez; Heiner Boeing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

3.  Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.

Authors:  Gregory S Cooper; Tzyung Doug Kou; Amitabh Chak
Journal:  Am J Gastroenterol       Date:  2009-05-12       Impact factor: 10.864

Review 4.  When mutants gain new powers: news from the mutant p53 field.

Authors:  Ran Brosh; Varda Rotter
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

5.  Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic.

Authors:  P Lao-Sirieix; A Boussioutas; S R Kadri; M O'Donovan; I Debiram; M Das; L Harihar; R C Fitzgerald
Journal:  Gut       Date:  2009-08-02       Impact factor: 23.059

6.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

7.  DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus.

Authors:  Jean S Wang; Mingzhou Guo; Elizabeth A Montgomery; Richard E Thompson; Hilary Cosby; Lisa Hicks; Shelun Wang; James G Herman; Marcia I Canto
Journal:  Am J Gastroenterol       Date:  2009-07-07       Impact factor: 10.864

8.  Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Thomas G Paulson; Carlo C Maley; Xiaohong Li; Hongzhe Li; Carissa A Sanchez; Dennis L Chao; Robert D Odze; Thomas L Vaughan; Patricia L Blount; Brian J Reid
Journal:  Clin Cancer Res       Date:  2009-05-05       Impact factor: 12.531

9.  Medication usage and the risk of neoplasia in patients with Barrett's esophagus.

Authors:  Dang M Nguyen; Hashem B El-Serag; Louise Henderson; Daniel Stein; Achyut Bhattacharyya; Richard E Sampliner
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-10       Impact factor: 11.382

10.  Attitudes, norms and controls influencing lifestyle risk factor management in general practice.

Authors:  Amanda J Ampt; Cheryl Amoroso; Mark F Harris; Suzanne H McKenzie; Vanessa K Rose; Jane R Taggart
Journal:  BMC Fam Pract       Date:  2009-08-26       Impact factor: 2.497

View more
  184 in total

1.  Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.

Authors:  Deirdre P Cronin-Fenton; Liam J Murray; David C Whiteman; Chris Cardwell; Penelope M Webb; Susan J Jordan; Douglas A Corley; Linda Sharp; Jesper Lagergren
Journal:  Eur J Cancer       Date:  2010-04-22       Impact factor: 9.162

Review 2.  Epigenetic biomarkers in esophageal cancer.

Authors:  Andrew M Kaz; William M Grady
Journal:  Cancer Lett       Date:  2012-03-07       Impact factor: 8.679

3.  Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus.

Authors:  Elizabeth L Bird-Lieberman; André A Neves; Pierre Lao-Sirieix; Maria O'Donovan; Marco Novelli; Laurence B Lovat; William S Eng; Lara K Mahal; Kevin M Brindle; Rebecca C Fitzgerald
Journal:  Nat Med       Date:  2012-01-15       Impact factor: 53.440

4.  A surprise cell of origin for Barrett's esophagus.

Authors:  Urs von Holzen; Greg H Enders
Journal:  Cancer Biol Ther       Date:  2012-06-01       Impact factor: 4.742

5.  Are we making progress in diagnosing and preventing gastrointestinal cancers?

Authors:  Jelle Haringsma; Nicoline C M van Heel; Ernst J Kuipers
Journal:  Therap Adv Gastroenterol       Date:  2010-07       Impact factor: 4.409

Review 6.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

7.  The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.

Authors:  Rom S Leidner; Lakshmeswari Ravi; Patrick Leahy; Yanwen Chen; Beth Bednarchik; Mirte Streppel; Marcia Canto; Jean S Wang; Anirban Maitra; Joseph Willis; Sanford D Markowitz; Jill Barnholtz-Sloan; Mark D Adams; Amitabh Chak; Kishore Guda
Journal:  Genes Chromosomes Cancer       Date:  2012-02-03       Impact factor: 5.006

Review 8.  Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.

Authors:  Sudhir Srivastava; Brian J Reid; Sharmistha Ghosh; Barnett S Kramer
Journal:  J Cell Physiol       Date:  2016-04-29       Impact factor: 6.384

9.  MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.

Authors:  Laura A Kresty; Jennifer Clarke; Kristin Ezell; Amy Exum; Amy B Howell; Toumy Guettouche
Journal:  J Carcinog       Date:  2011-12-22

Review 10.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.